Roche Diagnostics Launches EZH2 Mutations Test for Eisai’s Tazverik in Japan

Roche Diagnostics rolled out on September 6 its companion diagnostic EZH2 gene mutation detection kit for use in determining patients with EZH2 gene mutation-positive follicular lymphomas that would be suitable for treatment with Eisai’s oral EZH2 inhibitor Tazverik (tazemetostat). The...read more